Frontlight ResearchEarly access
Haemophilia trials in Croatia
3 of 7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleNuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
- Where
- Zagreb
- Age
- 12 years and over
- People
- 28 worldwide
- Run by
- Octapharma
See details and how to joinNCT05935358 - Phase 3Taking peopleOpen-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Where
- Grad Zagreb
- Age
- 1 year to 74 years
- People
- 245 worldwide
- Run by
- Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00 - Phase 4Taking peopleNuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)
- Where
- Grad Zagreb
- People
- 45 worldwide
- Run by
- Octapharma AG
See details and how to join2022-502060-21-00